SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
63 hedge funds and large institutions have $15.6M invested in Seelos Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
75% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 16
Holders
63
Holding in Top 10
–
Calls
$791K
Puts
$484K
Top Buyers
| 1 | +$592K | |
| 2 | +$69.3K | |
| 3 | +$36K | |
| 4 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$34K |
| 5 |
VF
Virtu Financial
New York
|
+$23K |
Top Sellers
| 1 | -$885K | |
| 2 | -$720K | |
| 3 | -$595K | |
| 4 |
E
Ergoteles
New York
|
-$416K |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$357K |